Parmax Pharma Ltd

In accordance with amendments to the SEBI (LODR) Regulations 2024 read with SEBI circular No. SEBI/HO/CFD-PoD2/CIR/P/2024/185 dated 31st December 2024 read with BSE circular no. 20250102-4 dated 2nd January 2025 the integrated filing of financial statements for the quarter ended on 31st December 2024 is attached herewith.